Abstract 3250: Comparative study of human and canine nerve sheath tumors in terms of morphology, prognosis, treatment, epigenetics, transcriptomics, and genomics

Abstract INTRODUCTION: Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas. An obstacle to treating MPNSTs is a lack of effective systemic therapies. Although over 70% of human MPNSTs have lost or inactivated the epigenome regulator polycomb repressive complex 2 (PRC2) (DeRaedt et al., Nature, 2014), its activity and contribution to canine PNST progression remain unclear. METHODS: This study compared canine peripheral nerve sheath tumors (PNSTs) and human MPNSTs across biological and clinical features, including PRC2 activity. Immunohistochemical analysis was performed for a human tissue microarray of 54 neurofibromas and 139 MPNSTs, and 63 canine PNSTs for H3K27me3, a repressive histone mark deposited by intact PRC2, and H3K27ac, which increases globally upon H3K27me3 loss. To understand the genomic alterations present in canine PNSTs, we analyzed tumor mutation burden, copy number alteration, and transcriptomes of eight canine PNST/normal pairs. RESULTS: The results suggested that H3K27me3 loss and associated gain of H3K27ac epigenetically drive human and canine tumors. This study provided evidence that human and canine PNSTs are clinicopathologically similar and may also be similarly driven by epigenetic mechanisms. CONCLUSIONS: Further studies are warranted to evaluate whether these epigenetic deregulations alter similar gene signatures in humans and canine patients. The knowledge gained from this work advances our understanding of the molecular drivers of MPNST and informs potential therapeutics to evaluate in future clinical studies. Citation Format: Jace P. Landry, Angela D. Bhalla, Sharon M. Landers, Rossana Lazcano, Lindsay A. Parker, Tasha M. Miller, Noelle Niemi, Heather G. Lyu, Heather A. Lillemoe, Emily Z. Keung, Christopher P. Scally, Christina L. Roland, Kelly K. Hunt, John M. Slopis, Ian E. McCutcheon, Beth Boudreau, Heather Wilson-Robles, Alexander J. Lazar, Kunal Rai, Dominique J. Wiener, Brian W. Davis, Brandan Wustefeld-Janssens, Keila E. Torres. Comparative study of human and canine nerve sheath tumors in terms of morphology, prognosis, treatment, epigenetics, transcriptomics, and genomics [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 3250.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-3250
Primary Topic
Veterinary Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 3250: Comparative study of human and canine nerve sheath tumors in terms of morphology, prognosis, treatment, epigenetics, transcriptomics, and genomics

Heather A. Lillemoe, Christopher P. Scally, Brian W. Davis, Kelly K. Hunt et al.
Cancer Research
Veterinary Oncology Research
article

Abstract 3250: Comparative study of human and canine nerve sheath tumors in terms of morphology, prognosis, treatment, epigenetics, transcriptomics, and genomics

Heather A. Lillemoe, Christopher P. Scally, Brian W. Davis, Kelly K. Hunt, John M. Slopis, Dominique J. Wiener, Rossana Lazcano, Lindsay A. Parker, Heather Lyu, Beth Boudreau, Sharon M. Landers, Jace P. Landry, Emily Z. Keung, I. McCutcheon, Angela D. Bhalla, Tasha Miller, Heather Wilson-Robles, Keila E. Torres, Brandan Wustefeld-Janssens, Christina L. Roland, Noelle Niemi, Kunal Rai, Alexander J. Lazar
article en

Abstract

Abstract INTRODUCTION: Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas. An obstacle to treating MPNSTs is a lack of effective systemic therapies. Although over 70% of human MPNSTs have lost or inactivated the epigenome regulator polycomb repressive complex 2 (PRC2) (DeRaedt et al., Nature, 2014), its activity and contribution to canine PNST progression remain unclear. METHODS: This study compared canine peripheral nerve sheath tumors (PNSTs) and human MPNSTs across biological and clinical features, including PRC2 activity. Immunohistochemical analysis was performed for a human tissue microarray of 54 neurofibromas and 139 MPNSTs, and 63 canine PNSTs for H3K27me3, a repressive histone mark deposited by intact PRC2, and H3K27ac, which increases globally upon H3K27me3 loss. To understand the genomic alterations present in canine PNSTs, we analyzed tumor mutation burden, copy number alteration, and transcriptomes of eight canine PNST/normal pairs. RESULTS: The results suggested that H3K27me3 loss and associated gain of H3K27ac epigenetically drive human and canine tumors. This study provided evidence that human and canine PNSTs are clinicopathologically similar and may also be similarly driven by epigenetic mechanisms. CONCLUSIONS: Further studies are warranted to evaluate whether these epigenetic deregulations alter similar gene signatures in humans and canine patients. The knowledge gained from this work advances our understanding of the molecular drivers of MPNST and informs potential therapeutics to evaluate in future clinical studies. Citation Format: Jace P. Landry, Angela D. Bhalla, Sharon M. Landers, Rossana Lazcano, Lindsay A. Parker, Tasha M. Miller, Noelle Niemi, Heather G. Lyu, Heather A. Lillemoe, Emily Z. Keung, Christopher P. Scally, Christina L. Roland, Kelly K. Hunt, John M. Slopis, Ian E. McCutcheon, Beth Boudreau, Heather Wilson-Robles, Alexander J. Lazar, Kunal Rai, Dominique J. Wiener, Brian W. Davis, Brandan Wustefeld-Janssens, Keila E. Torres. Comparative study of human and canine nerve sheath tumors in terms of morphology, prognosis, treatment, epigenetics, transcriptomics, and genomics [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 3250.

Cancer ResearchVol. 86(7_Supplement)
The University of Texas MD Anderson Cancer Center (US), Texas A&M University (US)
Openalex Percentile: Top 31%
Veterinary Oncology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.